...
机译:术前诊断胰头癌癌的门静脉侵袭:伴随门静脉切除的适当适应症
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Hokkaido Univ Dept Gastroenterol Surg 2 Grad Sch Med Kita Ku North 15 West 7 Sapporo Hokkaido;
Computed tomography; Pancreatic head cancer; Pathological invasion; Prediction; Surgical indication;
机译:术前诊断胰头癌癌的门静脉侵袭:伴随门静脉切除的适当适应症
机译:切除胰头癌患者门静脉/优质肠系膜静脉侵袭的预测与临床意义:术前CT参数的意义
机译:与门静脉浸润的胰腺导管腺癌门静脉切除术与门静脉腺癌的标准胰蛋白酶切除术。
机译:脂质体 - 亚霉素(Lipo-ADR)通过门静脉和肝动脉进行预防和治疗治疗晚期胃癌肝转移后的临床试验
机译:活体供体肝脾切除术及门静脉血栓形成的危险因素
机译:Neoadjuvant化疗随后通过缺术和血管切除在术前经皮肠道门静脉支架在局部晚期胰腺癌中进行总胰腺切除术与门静脉总爆破
机译:表5.5.a.1肿瘤大小和治疗(重新切性率)图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度,TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后,患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时,围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后,患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头